Q3 2026 results · 29 October 2026

Keytruda alone sold $8.6bn, almost half of Merck's $18.1bn quarter.

$8.6Bsales of Keytruda, almost half of the total

$694MWinrevair sales, up 93%

$18.1Btotal sales, up 5%

Source

Get a note when Merck & Co. reports next.

Whatco sends a short notification with the number that matters, and the full story of the company is a tap away.